New PET-scan method may sharpen brachytherapy for cervical cancer

NCT ID NCT03315351

Completed Knowledge-focused Sponsor: Centre Oscar Lambret Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether using a PET-scan at the start of brachytherapy (internal radiation) is feasible for patients with locally advanced cervical cancer. Fourteen participants who have already received chemoradiation will undergo an extra PET-scan during brachytherapy and another four months later. The goal is to see if this approach helps doctors better define the tumor target for treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to more precise brachytherapy for cervical cancer, potentially improving tumor targeting and reducing side effects.
What could go wrong: This is a very small, early feasibility study with only 14 participants. It does not test whether the approach actually improves outcomes, so it may not lead to any practical change in treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER

Contacts and locations

Locations

Centre Oscar Lambret

Lille, 59020, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.